Kenneth H Shain Selected Research

Kenneth H Shain Research Topics

Disease

39	Multiple Myeloma 04/2024 - 11/2003
16	Neoplasms (Cancer) 04/2024 - 03/2002
5	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 01/2017
4	Lymphoma (Lymphomas) 01/2022 - 01/2018
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2021 - 01/2017
3	Fanconi Anemia (Fanconi's Anemia) 11/2011 - 11/2003
2	Disease Progression 12/2023 - 01/2018
2	Cardiotoxicity 01/2023 - 01/2018
2	Heart Failure 01/2023 - 01/2023
1	Chromosome Aberrations (Chromosome Abnormalities) 04/2024
1	Chromothripsis 01/2024
1	Ventricular Tachycardia 01/2023
1	Atrial Fibrillation 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Cardiomyopathies (Cardiomyopathy) 01/2023
1	Cytopenia 12/2022
1	Infections 12/2022
1	Neoplasm Metastasis (Metastasis) 10/2022
1	Carcinoma (Carcinomatosis) 10/2022
1	Progressive Multifocal Leukoencephalopathy 01/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	Leukoencephalopathies 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Osteolysis 01/2021
1	Hypoxia (Hypoxemia) 01/2019
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2019
1	Mucositis 01/2019
1	Residual Neoplasm 04/2016
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2016
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2016
1	Renal Insufficiency (Renal Failure) 09/2013

Drug/Important Bio-Agent (IBA)

11	Lenalidomide (CC 5013)FDA Link 04/2024 - 09/2013
9	Dexamethasone (Maxidex)FDA LinkGeneric 04/2024 - 01/2014
8	Bortezomib (Velcade)FDA Link 04/2024 - 12/2009
6	daratumumabIBA 04/2024 - 01/2020
6	Proteasome InhibitorsIBA 01/2023 - 10/2015
6	Melphalan (Alkeran)FDA LinkGeneric 01/2021 - 11/2003
5	Proteins (Proteins, Gene)FDA Link 10/2023 - 03/2002
4	ibrutinibIBA 01/2021 - 01/2017
3	idecabtagene vicleucelIBA 09/2023 - 12/2022
2	Adenosine Monophosphate (AMP)IBA 04/2024 - 01/2024
2	RNA (Ribonucleic Acid)IBA 12/2023 - 05/2021
2	Chimeric Antigen ReceptorsIBA 09/2023 - 01/2023
2	carfilzomibIBA 01/2023 - 11/2016
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 05/2021
2	Histone Deacetylase InhibitorsIBA 12/2021 - 10/2021
2	Agammaglobulinaemia Tyrosine KinaseIBA 01/2021 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 12/2009
2	ONX 0912IBA 01/2019 - 01/2019
2	venetoclaxIBA 01/2019 - 01/2017
2	Alkylating AgentsIBA 01/2019 - 12/2009
2	Immunomodulating AgentsIBA 01/2018 - 10/2015
2	selinexorIBA 11/2016 - 01/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 10/2015
2	liposomal doxorubicin (Doxil)FDA Link 01/2016 - 01/2014
2	1-dodecylpyridoxal (PLD)IBA 01/2016 - 01/2014
1	Caseins (Casein)FDA Link 12/2023
1	SR-3029IBA 12/2023
1	SurvivinIBA 11/2023
1	VaccinesIBA 11/2023
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2023
1	B-Cell Maturation AntigenIBA 01/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	THZ531IBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	IgKIBA 01/2022
1	Histones (Histone)IBA 12/2021
1	LCL161IBA 10/2021
1	PanobinostatIBA 10/2021
1	Inhibitor of Apoptosis ProteinsIBA 10/2021
1	Protein Disulfide-IsomerasesIBA 05/2021
1	CytokinesIBA 05/2021
1	Matrix Metalloproteinase 13IBA 01/2021
1	ProdrugsIBA 01/2019
1	azomycinIBA 01/2019
1	TH 302IBA 01/2019
1	6-bromo-2-naphthyl sulfate (BNS)IBA 01/2019
1	isophosphamide mustard (IPAM)IBA 01/2019
1	Oncogene Proteins (Oncogene Protein)IBA 12/2018
1	Phosphotransferases (Kinase)IBA 12/2018
1	ricolinostatIBA 01/2017
1	Exportin 1 ProteinIBA 01/2016
1	Topoisomerase II InhibitorsIBA 01/2016
1	Thalidomide (Thalomid)FDA Link 10/2015
1	Cisplatin (Platino)FDA LinkGeneric 10/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2015
1	Vincristine (Oncovin)FDA LinkGeneric 10/2015
1	Etoposide (VP 16)FDA LinkGeneric 10/2015

Therapy/Procedure

23	Therapeutics 04/2024 - 12/2009
4	Stem Cell Transplantation 10/2023 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2017 - 10/2015
1	Transplantation 10/2023
1	Hematopoietic Stem Cell Mobilization 01/2023
1	Aftercare (After-Treatment) 01/2021
1	Transcutaneous Electric Nerve Stimulation (TENS) 01/2021
1	Immunomodulation 01/2018